Research Procedures nACHr

User login

View
What links here

Gallery:

Site Images

Illustrative research procedures for targeting the nicotine receptor (nACH) in the brain. Chantrix™ for smoking cessation was the first of many potential indications targeting this receptor. Expertise developed across these procedures is potentially leverageable for blockbuster⁺ drugs in the other medical indications (listed on the right).

Containing Articles

Scientific Competitive Edge

The material on this website may not be copied or reused in its entirety or substantially without the express permission of World Class R&D LLC, as per the Terms of Use. Short excerpts or citations do not require this permission as long as they are properly attributed. In general, all the materials on this website are the property of their respective owners or World Class R&D LLC.